Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion.

Background/objectives: Heated intraperitoneal chemotherapy (HIPEC) kills cancer cells via thermal injury and improved chemotherapeutic cytotoxicity. We hypothesize that higher HIPEC flow rates improve peritoneal heating and HIPEC efficacy.

Methods: (1) A HIPEC-model (30.